Personalis, Inc.
(NASDAQ : PSNL)

( )
PSNL After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 1.11%62.180.0%$1999.69m
REGNRegeneron Pharmaceuticals, Inc. -2.18%599.472.5%$1212.04m
GILDGilead Sciences, Inc. -3.43%75.161.0%$972.03m
NVAXNovavax, Inc. 14.73%52.82102.0%$711.68m
AMGNAmgen, Inc. -1.22%226.911.3%$619.06m
VRTXVertex Pharmaceuticals, Inc. -0.46%286.641.9%$592.02m
BIIBBiogen, Inc. -1.84%301.451.6%$385.60m
ILMNIllumina, Inc. 0.65%365.413.5%$384.25m
SRNESorrento Therapeutics, Inc. -0.99%5.001.8%$320.03m
ALXNAlexion Pharmaceuticals, Inc. -0.82%118.922.0%$296.17m
SGENSeattle Genetics, Inc. 1.15%159.026.1%$258.80m
AAgilent Technologies, Inc. 2.01%89.911.6%$212.68m
BMRNBioMarin Pharmaceutical, Inc. 0.79%107.394.3%$185.56m
MGNXMacroGenics, Inc. 9.67%21.106.2%$174.18m
INCYIncyte Corp. -0.16%101.752.5%$166.58m

Company Profile

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA.